The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Integrated Neurobiology of Bipolar Disorder
Open accessAbstract
From a neurobiological perspective there is no such thing as bipolar disorder. Rather, it is almost certainly the case that many somewhat similar, but subtly different, pathological conditions produce a disease state that we currently diagnose as bipolarity. This heterogeneity - reflected in the lack of synergy between our current diagnostic schema and our rapidly advancing scientific understanding of the condition - limits attempts to articulate an integrated perspective on bipolar disorder. However, despite these challenges, scientific findings in recent years are beginning to offer a provisional "unified field theory" of the disease. This theory sees bipolar disorder as a suite of related neurodevelopmental conditions with interconnected functional abnormalities that often appear early in life and worsen over time. In addition to accelerated loss of volume in brain areas known to be essential for mood regulation and cognitive function, consistent findings have emerged at a cellular level, providing evidence that bipolar disorder is reliably associated with dysregulation of glial-neuronal interactions. Among these glial elements are microglia - the brain's primary immune elements, which appear to be overactive in the context of bipolarity. Multiple studies now indicate that inflammation is also increased in the periphery of the body in both the depressive and manic phases of the illness, with at least some return to normality in the euthymic state. These findings are consistent with changes in the hypothalamic-pituitary-adrenal axis, which are known to drive inflammatory activation. In summary, the very fact that no single gene, pathway, or brain abnormality is likely to ever account for the condition is itself an extremely important first step in better articulating an integrated perspective on both its ontological status and pathogenesis. Whether this perspective will translate into the discovery of innumerable more homogeneous forms of bipolarity is one of the great questions facing the field and one that is likely to have profound treatment implications, given that fact that such a discovery would greatly increase our ability to individualize - and by extension, enhance - treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive and emotional influences in anterior cingulate cortex
Bush, G., Luu, P., & Posner, M. I. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01483-2 · Cited by 6,259 · cited 1×
“If conflict is detected dACC may engage lateral prefrontal cortical areas in order to establish control operations (111).”
BackgroundCommon polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Large-scale brain networks and psychopathology: a unifying triple network model
Menon, V. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.08.003 · Cited by 4,168
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Self-citationA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationHypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822 · cited 2×
“In addition to affecting autonomic and immune function, elevated glucocorticoids have been associated with suppression of thyroid-stimulating hormone secretion and compromised enzymatic conversion of relatively inactive thyroxine to active triiodothyronine (172).”
BackgroundGenetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“These disturbances are most likely attributable to deficits in cortico-limbic regulation in bipolar disorder, with consequent amygdala over-activity, and a compromised hippocampal regulatory role (169).”
BackgroundThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Pain and emotion interactions in subregions of the cingulate gyrus
Vogt, B. A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1704 · Cited by 1,810 · cited 1×
“Autonomic projections from sgACC to the amygdala, PAG, and nucleus tractus solitarius (NTS) in the medulla enable this “limbic” portion of ACC to instantiate an adaptive response to negative emotional events (113).”
MethodPrimate anterior cingulate cortex: Where motor control, drive and cognition interface
Paus, T. (2001) · Nature Reviews Neuroscience · doi:10.1038/35077500 · Cited by 1,722
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 1×
“Postmortem studies of bipolar patients have noted a reduction in both glial cell numbers and density (156).”
BackgroundA polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Phillips, M. L., Ladouceur, C. D., & Drevets, W. C. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.65 · Cited by 1,383 · cited 2×
“Decreased activity in the dorsolateral PFC in bipolar disorder may be associated with compromised working memory, impaired ability to sustain attention, and compromised executive function (103, 108).”
BackgroundPsychiatric GWAS Consortium Bipolar Disorder Working Group, Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., Edenberg, H. J., Nurnberger, J. I., Rietschel, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.943 · Cited by 1,344
The cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Reciprocal regulation of the neural and innate immune systems
Irwin, M. R., & Cole, S. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3042 · Cited by 910
Kempton, M. J., Salvador, Z., Munafò, M. R., Geddes, J. R., Simmons, A., Frangou, S., & Williams, S. C. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.60 · Cited by 886 · cited 1×
“Both disorders manifested a larger lateral ventricular volume and increased rates of subcortical gray-matter hyperintensities compared with healthy controls (151).”
BackgroundChang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019590 · Cited by 714 · cited 4×
“Astrocytes become unable to maintain the integrity of the blood–brain barrier and optimal neurovascular coupling (3).”
BackgroundInfluentialPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689 · cited 2×
“Astrocytes serve a number of functions including: maintenance of the blood–brain barrier and facilitation of neurovascular coupling (3); protection of the neuronal synapse (4) by removing excess ions to keep firing rate steady and removing excess glutamate before it can diffuse out of the synapse to bind to extrasynap…”
BackgroundComorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Lawrence, N. S., Williams, A. M., Surguladze, S., Giampietro, V., Brammer, M. J., Andrew, C., Frangou, S., Ecker, C., & Phillips, M. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.017 · Cited by 548 · cited 2×
“Its activity has been reported to be both reduced and elevated in the depressive state (103, 104) but appears to be predominantly decreased in bipolar mania (90, 105, 106).”
BackgroundResultLindqvist, D., Janelidze, S., Hagell, P., Erhardt, S., Samuelsson, M., Minthon, L., Hansson, O., Björkqvist, M., Träskman-Bendz, L., & Brundin, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.030 · Cited by 524
Simon, N. M., Smoller, J. W., McNamara, K. L., Maser, R. S., Zalta, A. K., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K.-K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.004 · Cited by 516 · cited 1×
“A recent study suggested that telomere shortening in mood disorders, most likely attributable to oxidative stress, may be equivalent to 10 years of accelerated aging (273).”
BackgroundHypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462 · cited 1×
“For example, hypomethylation of the COMT gene has been associated with both bipolar disorder and schizophrenia (67).”
BackgroundComparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Eisenberger, N. I., Inagaki, T. K., Mashal, N. M., & Irwin, M. R. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.12.009 · Cited by 413
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · cited 1×
“Both meta-analyses indicated higher levels of tumor necrosis factor (TNF)-alpha and IL-4 in bipolar subjects relative to healthy subjects (196, 197).”
Effects of medication on neuroimaging findings in bipolar disorder: an updated review
Hafeman, D. M., Chang, K. D., Garrett, A. S., Sanders, E. M., & Phillips, M. L. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01023.x · Cited by 379
McDonald, C., Bullmore, E. T., Sham, P. C., Chitnis, X., Wickham, H., Bramon, E., & Murray, R. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.974 · Cited by 379
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375
Alesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes
Hamidi, M., Drevets, W. C., & Price, J. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.006 · Cited by 369
Drevets, W. C., Öngür, D., & Price, J. L. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000370 · Cited by 352
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
A Causal Role for Brain-Derived Neurotrophic Factor in the Homeostatic Regulation of Sleep
Faraguna, U., Vyazovskiy, V. V., Nelson, A. B., Tononi, G., & Cirelli, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5510-07.2008 · Cited by 300
Cytokine levels in the blood may distinguish suicide attempters from depressed patients
Janelidze, S., Mattei, D., Westrin, Å., Träskman-Bendz, L., & Brundin, L. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.10.010 · Cited by 298
Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.
O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Bhat, S., Dao, D. T., Terrillion, C. E., Arad, M., Smith, R. J., Soldatov, N. M., & Gould, T. D. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.001 · Cited by 271
Inflammation selectively enhances amygdala activity to socially threatening images
Inagaki, T. K., Muscatell, K. A., Irwin, M. R., Cole, S. W., & Eisenberger, N. I. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.090 · Cited by 264
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264
Cytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256
Blumberg, H. P., Martin, A., Kaufman, J., Leung, H.-C., Skudlarski, P., Lacadie, C., Fulbright, R. K., Gore, J. C., Charney, D. S., Krystal, J. H., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1345 · Cited by 235 · cited 1×
“Imaging studies have reported functional and structural changes in the vmPFC of adolescents and young adult bipolar patients relative to healthy controls (95, 96).”
BackgroundIdentification of Pathways for Bipolar Disorder: A Meta-analysis
Nurnberger, J. I., Koller, D. L., Jung, J., Edenberg, H. J., Foroud, T., Guella, I., Vawter, M. P., & Kelsoe, J. R. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.176 · Cited by 234
Vostrikov, V. M., Uranova, N. A., & Orlovskaya, D. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.014 · Cited by 233
Gigante, A. D., Bond, D. J., Lafer, B., Lam, R. W., Young, L. T., & Yatham, L. N. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01033.x · Cited by 226
Altered gene expression of histone deacetylases in mood disorder patients
Hobara, T., Uchida, S., Otsuki, K., Matsubara, T., Funato, H., Matsuo, K., Suetsugi, M., & Watanabe, Y. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.015 · Cited by 185
The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia
Benes, F. M., Matzilevich, D., Burke, R. E., & Walsh, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001758 · Cited by 183
Regenold, W. T., Phatak, P., Marano, C. M., Gearhart, L., Viens, C. H., & Hisley, K. C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.019 · Cited by 178 · cited 1×
“Evidence of diminished myelin staining in the dorsolateral PFC and reductions of S100B immune-positive oligodendrocytes in the hippocampus of bipolar subjects further extend these findings (159, 160).”
ResultBlumberg, H. P., Krystal, J. H., Bansal, R., Martin, A., Dziura, J., Durkin, K., Martin, L., Gerard, E., Charney, D. S., & Peterson, B. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.031 · Cited by 171 · cited 2×
“Imaging studies have reported functional and structural changes in the vmPFC of adolescents and young adult bipolar patients relative to healthy controls (95, 96).”
BackgroundAssociations Between Bipolar Disorder and Metabolic Syndrome: A Review
Taylor, V., & MacQueen, G. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0704 · Cited by 152 · cited 3×
“Combined with autonomic disturbance, increased platelet/endothelial aggregation and unhealthful lifestyle, elevated inflammation may contribute to substantially increased risk of respiratory and gastrointestinal disorders, cerebrovascular and cardiovascular disease, and migraines in the bipolar population (79, 168, 20…”
BackgroundSavitz, J., Frank, M. B., Victor, T., Bebak, M., Marino, J. H., Bellgowan, P. S. F., McKinney, B. A., Bodurka, J., Kent Teague, T., & Drevets, W. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.007 · Cited by 146 · cited 3×
“Increased oxidative stress may further compromise monoamine synthesis by depleting BH4 (tetrahydrobiopterin), a key coenzyme in monoamine synthesis (207, 213).”
BackgroundBechdolf, A., Ratheesh, A., Cotton, S. M., Nelson, B., Chanen, A. M., Betts, J., Bingmann, T., Yung, A. R., Berk, M., & McGorry, P. D. (2014) · Bipolar Disorders · doi:10.1111/bdi.12205 · Cited by 132 · cited 2×
“Utilizing bipolar-at-risk (BAR) criteria at baseline, which include items reflecting genetic risk (first degree relative suffering from bipolar disorder), depressive, cyclothymic, and sub-threshold mania features, investigators prospectively, over a 12-month period, predicted first episodes of mania/hypomania (74).”
BackgroundDiniz, B., Machado-Vieira, R., & Forlenza (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s33086 · Cited by 128 · cited 1×
“, lithium) have been reported to increase hippocampal volume (122, 123).”
BackgroundMetabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap
McIntyre, R. S., Rasgon, N. L., Kemp, D. E., Nguyen, H. T., Law, C. W. Y., Taylor, V. H., Woldeyohannes, H. O., Alsuwaidan, M. T., Soczynska, J. K., Kim, B., et al. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0010-0 · Cited by 127
Krüger, S., Seminowicz, D., Goldapple, K., Kennedy, S. H., & Mayberg, H. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00691-7 · Cited by 127
Impact of Genetic Variant BDNF (Val66Met) on Brain Structure and Function
Chen, Z., Bath, K., McEwen, B., Hempstead, B., & Lee, F. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch14 · Cited by 119
Gos, T., Schroeter, M. L., Lessel, W., Bernstein, H.-G., Dobrowolny, H., Schiltz, K., Bogerts, B., & Steiner, J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.005 · Cited by 106
Colla, M., Schubert, F., Bubner, M., Heidenreich, J. O., Bajbouj, M., Seifert, F., Luborzewski, A., Heuser, I., & Kronenberg, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.26 · Cited by 106 · cited 1×
“Interestingly, one of the studies demonstrated an inverse relationship between diurnal salivary cortisol levels and hippocampal glutamate concentration in bipolar patients (262).”
BackgroundCytokine levels in euthymic bipolar patients
Guloksuz, S., Aktas Cetin, E., Cetin, T., Deniz, G., Oral, E. T., & Nutt, D. J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.027 · Cited by 102 · cited 1×
“Overall, the data suggest that successful treatment leading to a euthymic state may reverse inflammation and normalize peripheral levels of inflammatory mediators (195, 196, 202).”
BackgroundFrye, M. A., Denicoff, K. D., Bryan, A. L., Smith-Jackson, E. E., Ali, S. O., Luckenbaugh, D., Leverich, G. S., & Post, R. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1909 · Cited by 95
Schüle, C., Zill, P., Baghai, T. C., Eser, D., Zwanzger, P., Wenig, N., Rupprecht, R., & Bondy, B. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.06.002 · Cited by 94
De Dios, C., Ezquiaga, E., Agud, J. L., Vieta, E., Soler, B., & García-López, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.047 · Cited by 53
Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder
Yatham, L. N., Kapczinski, F., Andreazza, A. C., Trevor Young, L., Lam, R. W., & Kauer-Sant'Anna, M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009449 · Cited by 52
A family-based study of common polygenic variation and risk of schizophrenia
Ruderfer, D. M., Kirov, G., Chambert, K., Moran, J. L., Owen, M. J., O'Donovan, M. C., Sklar, P., & Purcell, S. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.34 · Cited by 28
Hakamata, Y., Iwase, M., Kato, T., Senda, K., & Inada, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075526 · Cited by 16
Cited by
Agnew-Blais, J., & Danese, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00544-1 · Cited by 421
The HPA axis in bipolar disorder: Systematic review and meta-analysis
Belvederi Murri, M., Prestia, D., Mondelli, V., Pariante, C., Patti, S., Olivieri, B., Arzani, C., Masotti, M., Respino, M., Antonioli, M., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.014 · Cited by 391
Diversity and plasticity of microglial cells in psychiatric and neurological disorders
Nakagawa, Y., & Chiba, K. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.010 · Cited by 208
Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187
Mood disorders in the elderly: prevalence, functional impact, and management challenges
Forlenza, O. V., Valiengo, L., & Stella, F. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s94643 · Cited by 129
Metadata
- Authors
- Maletic, V., & Raison, C.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2014-08-25
- Volume
- 5
- Pages
- 98-98
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2058448129
- Cited by
- 226
- References
- 70
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.